Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants

Neutralizing antibodies elicited by prior infection or vaccination are likely to be key for future protection of individuals and populations against SARS-CoV-2. Moreover, passively administered antibodies are among the most promising therapeutic and prophylactic anti-SARS-CoV-2 agents. However, the...

詳細記述

保存先:
書誌詳細
出版年:eLife
主要な著者: Weisblum, Yiska, Schmidt, Fabian, Zhang, Fengwen, DaSilva, Justin, Poston, Daniel, Lorenzi, Julio CC, Muecksch, Frauke, Rutkowska, Magdalena, Hoffmann, Hans-Heinrich, Michailidis, Eleftherios, Gaebler, Christian, Agudelo, Marianna, Cho, Alice, Wang, Zijun, Gazumyan, Anna, Cipolla, Melissa, Luchsinger, Larry, Hillyer, Christopher D, Caskey, Marina, Robbiani, Davide F, Rice, Charles M, Nussenzweig, Michel C, Hatziioannou, Theodora, Bieniasz, Paul D
フォーマット: Artigo
言語:Inglês
出版事項: eLife Sciences Publications, Ltd 2020
主題:
Immunology and Inflammation
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7723407/
https://ncbi.nlm.nih.gov/pubmed/33112236
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7554/eLife.61312
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料